Lead Plaintiff Deadline Approaching in ACHC: Kessler Topaz Meltzer & Check, LLP Reminds Investors A Securities Fraud Class Action Has Been Filed Against Acadia Healthcare Company, Inc.

Core Viewpoint - A securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. for allegedly making false and misleading statements regarding its business practices and patient treatment during the Class Period from February 28, 2020, to October 18, 2024 [1]. Group 1: Allegations Against Acadia Healthcare - The lawsuit claims that Acadia Healthcare's business model involved holding vulnerable individuals against their will in facilities, even when not medically necessary [3]. - It is alleged that many patients in Acadia Healthcare facilities experienced abuse [3]. - The company is accused of deceiving insurance providers into covering unnecessary stays for patients in its facilities [3]. - As a result of these practices, the statements made by Acadia Healthcare regarding its business operations and prospects were deemed materially false and misleading [3]. Group 2: Legal Process and Participation - Investors in Acadia Healthcare have until December 16, 2024, to seek appointment as a lead plaintiff representative in the class action lawsuit [4]. - A lead plaintiff acts on behalf of all class members and typically has the largest financial interest in the case [4]. - Investors can choose to participate actively or remain as absent class members without affecting their ability to share in any recovery [4]. Group 3: Law Firm Information - Kessler Topaz Meltzer & Check, LLP is the law firm handling the class action and has a reputation for recovering billions for victims of corporate misconduct [6]. - The firm encourages affected investors to contact them for more information regarding the lawsuit [5].